Oraquick HCV Rapid Antibody Test

DEVICE2 trials

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM), TruCare Internal Medicine & Infectious Disease

Conditions

Active or Ex-injection Drug UsersHepatitis CIndication of Hepatitis C Screening

Early Phase 1

Identification to Elimination in HCV-Infected Individuals

CompletedNCT03195205

TruCare Internal Medicine & Infectious DiseaseHepatitis C

Start: 2017-06-01End: 2020-04-20Updated: 2020-07-02

Unknown Phase

Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

TerminatedNCT02084719

Centre hospitalier de l'Université de Montréal (CHUM)Active or Ex-injection Drug Users, Indication of Hepatitis C Screening

Start: 2014-03-31End: 2016-04-30Updated: 2017-01-20